Cargando…

The migraine signature study: Methods and baseline results

OBJECTIVE: To characterize patients who utilize services for migraine in a large integrated health care network, and describe patterns of care and utilization. BACKGROUND: Within health care systems, migraine is a common reason for seeking primary and neurology care, but relatively little is documen...

Descripción completa

Detalles Bibliográficos
Autores principales: Pressman, Alice R., Buse, Dawn C., Jacobson, Alice S., Vaidya, Shruti J., Scott, Alexandra B., Chia, Victoria M., Szekely, Christine A., Stewart, Walter F., Lipton, Richard B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8048806/
https://www.ncbi.nlm.nih.gov/pubmed/33368248
http://dx.doi.org/10.1111/head.14033
_version_ 1783679299500376064
author Pressman, Alice R.
Buse, Dawn C.
Jacobson, Alice S.
Vaidya, Shruti J.
Scott, Alexandra B.
Chia, Victoria M.
Szekely, Christine A.
Stewart, Walter F.
Lipton, Richard B.
author_facet Pressman, Alice R.
Buse, Dawn C.
Jacobson, Alice S.
Vaidya, Shruti J.
Scott, Alexandra B.
Chia, Victoria M.
Szekely, Christine A.
Stewart, Walter F.
Lipton, Richard B.
author_sort Pressman, Alice R.
collection PubMed
description OBJECTIVE: To characterize patients who utilize services for migraine in a large integrated health care network, and describe patterns of care and utilization. BACKGROUND: Within health care systems, migraine is a common reason for seeking primary and neurology care, but relatively little is documented about who seeks care and the factors that explain variation in utilization. METHODS: We conducted a retrospective cohort study using electronic health record (EHR) data from Sutter Health primary care (PC) patients who had at least one office visit to a PC clinic between 2013 and 2017. Migraine status was ascertained from diagnosis codes and medication orders. Control status was assigned to those with no evidence of care for any type of headache. We divided the primary care migraine cohort into two groups: those who received all their care for migraine from PC (denoted PC‐M) and those who had ≥1 encounter with a neurologist for migraine (denoted N‐M). Migraine cases were also designated as having preexisting migraine if they had an encounter with a migraine diagnosis within (±) 6 months of their first study period PC visit and, otherwise, designated as first migraine consult. Two levels of contrasts included: patients with migraine and controls; and within the group of patients with migraine, PC‐M and N‐M groups. Comorbid conditions were determined from EHR encounter diagnosis codes. RESULTS: We identified 94,149 patients with migraine (including 21,525 N‐M and 72,624 PC‐M) and 1,248,763 controls. Comorbidities: Proportions of psychiatric [29.8% (n = 28,054) vs. 11.8% (n = 147,043)], autoimmune [(4.4% (n = 4162) vs. 2.6% (n = 31,981)], pain [13.2% (n = 12,439) vs. 5.8% (n = 72,049)], respiratory [24.6% (n = 23,186) vs. 12.3% (n = 153,692)], neurologic [2.9% (n = 2688) vs. 0.9% (n = 11,321)], and cerebrovascular [1.0% (n = 945) vs. 0.6% (n = 7500)] conditions were higher in the migraine group compared to controls, all p < 0.001. Among patients with migraine, the N‐M group was similar to the PC‐M group in sex, age, ethnicity, and marital status, but were more likely to have preexisting migraine (49.9% (n = 10,734) vs. 36.2% (n = 26,317), p < 0.001). Proportions of comorbid conditions were higher among the N‐M group than the PC‐M group {psychiatric [38.5% (n = 8291) vs. 27.2% (n = 19,763)], autoimmune [6.3% (n = 1365) vs. 3.9% (n = 2797)], pain [19.6% (n = 4218) vs. 11.3% (n = 8211)], respiratory [30.3% (n = 6516) vs. 23.0% (n = 16,670)], neurologic [6.0% (n = 1288) vs. 1.9% (n = 1400)], cardiovascular [9.7% (n = 2091) vs. 7.0% (n = 5076)], and cerebrovascular [2.3% (n = 500) vs. 0.6% (n = 445)], all p < 0.001}. Medications: During the study period, 82.6% (n = 77,762) of patients with migraine received ≥1 prescription order for an acute migraine medication [89.4% (n = 19,250) of N‐M vs. 80.6% (n = 58,512) of PC]. Opioids were prescribed to 52.9% (n = 49,837) of patients with migraine [63.5% (n = 13,669) for N‐M and 49.8% (n = 36,168) for PC‐M patients). During the study period, 61.4% (n = 57,810) of patients received ≥1 prescription for a migraine preventive medication [81.4% (n = 17,521) of N‐M and 55.5% (n = 40,289) of PC‐M patients]. The most commonly prescribed classes of preventive medications were antidepressants. CONCLUSIONS: Among patients with migraine in a large health system, those who were also cared for in neurology were more likely to receive both acute and preventive medication migraine orders than those patients who did not see a neurologist, with triptans and antidepressants the most commonly prescribed classes of acute and preventive pharmacotherapies, respectively. Opioids were prescribed to approximately half of the total sample and more common in the N‐M group. Adjusting for demographics, patients with migraine had higher rates of nearly every comorbidity we assessed and were more likely to utilize services compared to those without migraine. Overall, patients with migraine also cared for in neurology practices used more of all health care resource types under consideration and had more medical issues, which may be due in some part to a more severe, frequent and disabling disease state compared to those who sought care exclusively from PC practices.
format Online
Article
Text
id pubmed-8048806
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-80488062021-04-20 The migraine signature study: Methods and baseline results Pressman, Alice R. Buse, Dawn C. Jacobson, Alice S. Vaidya, Shruti J. Scott, Alexandra B. Chia, Victoria M. Szekely, Christine A. Stewart, Walter F. Lipton, Richard B. Headache Research Submissions OBJECTIVE: To characterize patients who utilize services for migraine in a large integrated health care network, and describe patterns of care and utilization. BACKGROUND: Within health care systems, migraine is a common reason for seeking primary and neurology care, but relatively little is documented about who seeks care and the factors that explain variation in utilization. METHODS: We conducted a retrospective cohort study using electronic health record (EHR) data from Sutter Health primary care (PC) patients who had at least one office visit to a PC clinic between 2013 and 2017. Migraine status was ascertained from diagnosis codes and medication orders. Control status was assigned to those with no evidence of care for any type of headache. We divided the primary care migraine cohort into two groups: those who received all their care for migraine from PC (denoted PC‐M) and those who had ≥1 encounter with a neurologist for migraine (denoted N‐M). Migraine cases were also designated as having preexisting migraine if they had an encounter with a migraine diagnosis within (±) 6 months of their first study period PC visit and, otherwise, designated as first migraine consult. Two levels of contrasts included: patients with migraine and controls; and within the group of patients with migraine, PC‐M and N‐M groups. Comorbid conditions were determined from EHR encounter diagnosis codes. RESULTS: We identified 94,149 patients with migraine (including 21,525 N‐M and 72,624 PC‐M) and 1,248,763 controls. Comorbidities: Proportions of psychiatric [29.8% (n = 28,054) vs. 11.8% (n = 147,043)], autoimmune [(4.4% (n = 4162) vs. 2.6% (n = 31,981)], pain [13.2% (n = 12,439) vs. 5.8% (n = 72,049)], respiratory [24.6% (n = 23,186) vs. 12.3% (n = 153,692)], neurologic [2.9% (n = 2688) vs. 0.9% (n = 11,321)], and cerebrovascular [1.0% (n = 945) vs. 0.6% (n = 7500)] conditions were higher in the migraine group compared to controls, all p < 0.001. Among patients with migraine, the N‐M group was similar to the PC‐M group in sex, age, ethnicity, and marital status, but were more likely to have preexisting migraine (49.9% (n = 10,734) vs. 36.2% (n = 26,317), p < 0.001). Proportions of comorbid conditions were higher among the N‐M group than the PC‐M group {psychiatric [38.5% (n = 8291) vs. 27.2% (n = 19,763)], autoimmune [6.3% (n = 1365) vs. 3.9% (n = 2797)], pain [19.6% (n = 4218) vs. 11.3% (n = 8211)], respiratory [30.3% (n = 6516) vs. 23.0% (n = 16,670)], neurologic [6.0% (n = 1288) vs. 1.9% (n = 1400)], cardiovascular [9.7% (n = 2091) vs. 7.0% (n = 5076)], and cerebrovascular [2.3% (n = 500) vs. 0.6% (n = 445)], all p < 0.001}. Medications: During the study period, 82.6% (n = 77,762) of patients with migraine received ≥1 prescription order for an acute migraine medication [89.4% (n = 19,250) of N‐M vs. 80.6% (n = 58,512) of PC]. Opioids were prescribed to 52.9% (n = 49,837) of patients with migraine [63.5% (n = 13,669) for N‐M and 49.8% (n = 36,168) for PC‐M patients). During the study period, 61.4% (n = 57,810) of patients received ≥1 prescription for a migraine preventive medication [81.4% (n = 17,521) of N‐M and 55.5% (n = 40,289) of PC‐M patients]. The most commonly prescribed classes of preventive medications were antidepressants. CONCLUSIONS: Among patients with migraine in a large health system, those who were also cared for in neurology were more likely to receive both acute and preventive medication migraine orders than those patients who did not see a neurologist, with triptans and antidepressants the most commonly prescribed classes of acute and preventive pharmacotherapies, respectively. Opioids were prescribed to approximately half of the total sample and more common in the N‐M group. Adjusting for demographics, patients with migraine had higher rates of nearly every comorbidity we assessed and were more likely to utilize services compared to those without migraine. Overall, patients with migraine also cared for in neurology practices used more of all health care resource types under consideration and had more medical issues, which may be due in some part to a more severe, frequent and disabling disease state compared to those who sought care exclusively from PC practices. John Wiley and Sons Inc. 2020-12-23 2021-03 /pmc/articles/PMC8048806/ /pubmed/33368248 http://dx.doi.org/10.1111/head.14033 Text en © 2020 Sutter Health Research. Headache: The Journal of Head and Face Pain published by Wiley Periodicals LLC, on behalf of American Headache Society https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Research Submissions
Pressman, Alice R.
Buse, Dawn C.
Jacobson, Alice S.
Vaidya, Shruti J.
Scott, Alexandra B.
Chia, Victoria M.
Szekely, Christine A.
Stewart, Walter F.
Lipton, Richard B.
The migraine signature study: Methods and baseline results
title The migraine signature study: Methods and baseline results
title_full The migraine signature study: Methods and baseline results
title_fullStr The migraine signature study: Methods and baseline results
title_full_unstemmed The migraine signature study: Methods and baseline results
title_short The migraine signature study: Methods and baseline results
title_sort migraine signature study: methods and baseline results
topic Research Submissions
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8048806/
https://www.ncbi.nlm.nih.gov/pubmed/33368248
http://dx.doi.org/10.1111/head.14033
work_keys_str_mv AT pressmanalicer themigrainesignaturestudymethodsandbaselineresults
AT busedawnc themigrainesignaturestudymethodsandbaselineresults
AT jacobsonalices themigrainesignaturestudymethodsandbaselineresults
AT vaidyashrutij themigrainesignaturestudymethodsandbaselineresults
AT scottalexandrab themigrainesignaturestudymethodsandbaselineresults
AT chiavictoriam themigrainesignaturestudymethodsandbaselineresults
AT szekelychristinea themigrainesignaturestudymethodsandbaselineresults
AT stewartwalterf themigrainesignaturestudymethodsandbaselineresults
AT liptonrichardb themigrainesignaturestudymethodsandbaselineresults
AT pressmanalicer migrainesignaturestudymethodsandbaselineresults
AT busedawnc migrainesignaturestudymethodsandbaselineresults
AT jacobsonalices migrainesignaturestudymethodsandbaselineresults
AT vaidyashrutij migrainesignaturestudymethodsandbaselineresults
AT scottalexandrab migrainesignaturestudymethodsandbaselineresults
AT chiavictoriam migrainesignaturestudymethodsandbaselineresults
AT szekelychristinea migrainesignaturestudymethodsandbaselineresults
AT stewartwalterf migrainesignaturestudymethodsandbaselineresults
AT liptonrichardb migrainesignaturestudymethodsandbaselineresults